At Inpharmation, we developed the Pharma-Specific Conjoint platform specifically to address the challenges of reliability and sample size in pharma market research. We transform preference shares into more accurate market shares before finally incorporating the additional jigsaw pieces to generate pharma-validated, forecast-ready market shares. This series of papers will show you the key steps to adapting conjoint to make it fit for pharma.